Oncology & Cancer Drugs Market, Global Outlook and Forecast 2024-2030
Report ID
47296
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
122
Editor's Rating
US $3,250.00
US $4,225.00
US $4,875.00
  • Report Details 
    This research report provides a comprehensive analysis of the Oncology & Cancer Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Oncology & Cancer Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Oncology & Cancer Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Oncology & Cancer Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Oncology & Cancer Drugs market presents opportunities for various stakeholders, including Blood Cancer, Breast Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Oncology & Cancer Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Oncology & Cancer Drugs market was valued at US$ 88290 million in 2023 and is projected to reach US$ 123890 million by 2030, at a CAGR of 4.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Oncology & Cancer Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Oncology & Cancer Drugs market.
Market Overview: The report provides a comprehensive overview of the Oncology & Cancer Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antimetabolite, Alkaloid drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Oncology & Cancer Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Oncology & Cancer Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Oncology & Cancer Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. 
Market Segmentation and Forecast: The report segment the Oncology & Cancer Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Oncology & Cancer Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Oncology & Cancer Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Oncology & Cancer Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Oncology & Cancer Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Oncology & Cancer Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
    Antimetabolite
    Alkaloid drugs
    Hormone
    Targeted drug
    Platinum-based drugs
    Other
Market segment by Application
    Blood Cancer
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Respiratory/Lung Cancer
    Other
Global Oncology & Cancer Drugs Market Segment Percentages, By Region and Country, 2023 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Major players covered
    Roche
    HENGRUI
    AstraZeneca
    QILU
    Sanofi
    HANSOH
    LUYE
    Novartis
    GuiZhou YiBai
    Lunan
    Eli Lilly and Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology & Cancer Drugs, market overview.
Chapter 2: Global Oncology & Cancer Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Oncology & Cancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology & Cancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oncology & Cancer Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
  • Table Of Content 
    1 Introduction to Research & Analysis Reports
    1.1 Oncology & Cancer Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Oncology & Cancer Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Oncology & Cancer Drugs Overall Market Size
    2.1 Global Oncology & Cancer Drugs Market Size: 2023 VS 2030
    2.2 Global Oncology & Cancer Drugs Revenue, Prospects & Forecasts: 2019-2030
    2.3 Global Oncology & Cancer Drugs Sales: 2019-2030
3 Company Landscape
    3.1 Top Oncology & Cancer Drugs Players in Global Market
    3.2 Top Global Oncology & Cancer Drugs Companies Ranked by Revenue
    3.3 Global Oncology & Cancer Drugs Revenue by Companies
    3.4 Global Oncology & Cancer Drugs Sales by Companies
    3.5 Global Oncology & Cancer Drugs Price by Manufacturer (2019-2024)
    3.6 Top 3 and Top 5 Oncology & Cancer Drugs Companies in Global Market, by Revenue in 2023
    3.7 Global Manufacturers Oncology & Cancer Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Oncology & Cancer Drugs Players in Global Market
        3.8.1 List of Global Tier 1 Oncology & Cancer Drugs Companies
        3.8.2 List of Global Tier 2 and Tier 3 Oncology & Cancer Drugs Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Oncology & Cancer Drugs Market Size Markets, 2023 & 2030
        4.1.2 Antimetabolite
        4.1.3 Alkaloid drugs
        4.1.4 Hormone
        4.1.5 Targeted drug
        4.1.6 Platinum-based drugs
        4.1.7 Other
    4.2 By Type - Global Oncology & Cancer Drugs Revenue & Forecasts
        4.2.1 By Type - Global Oncology & Cancer Drugs Revenue, 2019-2024
        4.2.2 By Type - Global Oncology & Cancer Drugs Revenue, 2025-2030
        4.2.3 By Type - Global Oncology & Cancer Drugs Revenue Market Share, 2019-2030
    4.3 By Type - Global Oncology & Cancer Drugs Sales & Forecasts
        4.3.1 By Type - Global Oncology & Cancer Drugs Sales, 2019-2024
        4.3.2 By Type - Global Oncology & Cancer Drugs Sales, 2025-2030
        4.3.3 By Type - Global Oncology & Cancer Drugs Sales Market Share, 2019-2030
    4.4 By Type - Global Oncology & Cancer Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Oncology & Cancer Drugs Market Size, 2023 & 2030
        5.1.2 Blood Cancer
        5.1.3 Breast Cancer
        5.1.4 Gastrointestinal Cancer
        5.1.5 Prostate Cancer
        5.1.6 Respiratory/Lung Cancer
        5.1.7 Other
    5.2 By Application - Global Oncology & Cancer Drugs Revenue & Forecasts
        5.2.1 By Application - Global Oncology & Cancer Drugs Revenue, 2019-2024
        5.2.2 By Application - Global Oncology & Cancer Drugs Revenue, 2025-2030
        5.2.3 By Application - Global Oncology & Cancer Drugs Revenue Market Share, 2019-2030
    5.3 By Application - Global Oncology & Cancer Drugs Sales & Forecasts
        5.3.1 By Application - Global Oncology & Cancer Drugs Sales, 2019-2024
        5.3.2 By Application - Global Oncology & Cancer Drugs Sales, 2025-2030
        5.3.3 By Application - Global Oncology & Cancer Drugs Sales Market Share, 2019-2030
    5.4 By Application - Global Oncology & Cancer Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
    6.1 By Region - Global Oncology & Cancer Drugs Market Size, 2023 & 2030
    6.2 By Region - Global Oncology & Cancer Drugs Revenue & Forecasts
        6.2.1 By Region - Global Oncology & Cancer Drugs Revenue, 2019-2024
        6.2.2 By Region - Global Oncology & Cancer Drugs Revenue, 2025-2030
        6.2.3 By Region - Global Oncology & Cancer Drugs Revenue Market Share, 2019-2030
    6.3 By Region - Global Oncology & Cancer Drugs Sales & Forecasts
        6.3.1 By Region - Global Oncology & Cancer Drugs Sales, 2019-2024
        6.3.2 By Region - Global Oncology & Cancer Drugs Sales, 2025-2030
        6.3.3 By Region - Global Oncology & Cancer Drugs Sales Market Share, 2019-2030
    6.4 North America
        6.4.1 By Country - North America Oncology & Cancer Drugs Revenue, 2019-2030
        6.4.2 By Country - North America Oncology & Cancer Drugs Sales, 2019-2030
        6.4.3 US Oncology & Cancer Drugs Market Size, 2019-2030
        6.4.4 Canada Oncology & Cancer Drugs Market Size, 2019-2030
        6.4.5 Mexico Oncology & Cancer Drugs Market Size, 2019-2030
    6.5 Europe
        6.5.1 By Country - Europe Oncology & Cancer Drugs Revenue, 2019-2030
        6.5.2 By Country - Europe Oncology & Cancer Drugs Sales, 2019-2030
        6.5.3 Germany Oncology & Cancer Drugs Market Size, 2019-2030
        6.5.4 France Oncology & Cancer Drugs Market Size, 2019-2030
        6.5.5 U.K. Oncology & Cancer Drugs Market Size, 2019-2030
        6.5.6 Italy Oncology & Cancer Drugs Market Size, 2019-2030
        6.5.7 Russia Oncology & Cancer Drugs Market Size, 2019-2030
        6.5.8 Nordic Countries Oncology & Cancer Drugs Market Size, 2019-2030
        6.5.9 Benelux Oncology & Cancer Drugs Market Size, 2019-2030
    6.6 Asia
        6.6.1 By Region - Asia Oncology & Cancer Drugs Revenue, 2019-2030
        6.6.2 By Region - Asia Oncology & Cancer Drugs Sales, 2019-2030
        6.6.3 China Oncology & Cancer Drugs Market Size, 2019-2030
        6.6.4 Japan Oncology & Cancer Drugs Market Size, 2019-2030
        6.6.5 South Korea Oncology & Cancer Drugs Market Size, 2019-2030
        6.6.6 Southeast Asia Oncology & Cancer Drugs Market Size, 2019-2030
        6.6.7 India Oncology & Cancer Drugs Market Size, 2019-2030
    6.7 South America
        6.7.1 By Country - South America Oncology & Cancer Drugs Revenue, 2019-2030
        6.7.2 By Country - South America Oncology & Cancer Drugs Sales, 2019-2030
        6.7.3 Brazil Oncology & Cancer Drugs Market Size, 2019-2030
        6.7.4 Argentina Oncology & Cancer Drugs Market Size, 2019-2030
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Oncology & Cancer Drugs Revenue, 2019-2030
        6.8.2 By Country - Middle East & Africa Oncology & Cancer Drugs Sales, 2019-2030
        6.8.3 Turkey Oncology & Cancer Drugs Market Size, 2019-2030
        6.8.4 Israel Oncology & Cancer Drugs Market Size, 2019-2030
        6.8.5 Saudi Arabia Oncology & Cancer Drugs Market Size, 2019-2030
        6.8.6 UAE Oncology & Cancer Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
    7.1 Roche
        7.1.1 Roche Company Summary
        7.1.2 Roche Business Overview
        7.1.3 Roche Oncology & Cancer Drugs Major Product Offerings
        7.1.4 Roche Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
        7.1.5 Roche Key News & Latest Developments
    7.2 HENGRUI
        7.2.1 HENGRUI Company Summary
        7.2.2 HENGRUI Business Overview
        7.2.3 HENGRUI Oncology & Cancer Drugs Major Product Offerings
        7.2.4 HENGRUI Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
        7.2.5 HENGRUI Key News & Latest Developments
    7.3 AstraZeneca
        7.3.1 AstraZeneca Company Summary
        7.3.2 AstraZeneca Business Overview
        7.3.3 AstraZeneca Oncology & Cancer Drugs Major Product Offerings
        7.3.4 AstraZeneca Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
        7.3.5 AstraZeneca Key News & Latest Developments
    7.4 QILU
        7.4.1 QILU Company Summary
        7.4.2 QILU Business Overview
        7.4.3 QILU Oncology & Cancer Drugs Major Product Offerings
        7.4.4 QILU Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
        7.4.5 QILU Key News & Latest Developments
    7.5 Sanofi
        7.5.1 Sanofi Company Summary
        7.5.2 Sanofi Business Overview
        7.5.3 Sanofi Oncology & Cancer Drugs Major Product Offerings
        7.5.4 Sanofi Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
        7.5.5 Sanofi Key News & Latest Developments
    7.6 HANSOH
        7.6.1 HANSOH Company Summary
        7.6.2 HANSOH Business Overview
        7.6.3 HANSOH Oncology & Cancer Drugs Major Product Offerings
        7.6.4 HANSOH Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
        7.6.5 HANSOH Key News & Latest Developments
    7.7 LUYE
        7.7.1 LUYE Company Summary
        7.7.2 LUYE Business Overview
        7.7.3 LUYE Oncology & Cancer Drugs Major Product Offerings
        7.7.4 LUYE Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
        7.7.5 LUYE Key News & Latest Developments
    7.8 Novartis
        7.8.1 Novartis Company Summary
        7.8.2 Novartis Business Overview
        7.8.3 Novartis Oncology & Cancer Drugs Major Product Offerings
        7.8.4 Novartis Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
        7.8.5 Novartis Key News & Latest Developments
    7.9 GuiZhou YiBai
        7.9.1 GuiZhou YiBai Company Summary
        7.9.2 GuiZhou YiBai Business Overview
        7.9.3 GuiZhou YiBai Oncology & Cancer Drugs Major Product Offerings
        7.9.4 GuiZhou YiBai Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
        7.9.5 GuiZhou YiBai Key News & Latest Developments
    7.10 Lunan
        7.10.1 Lunan Company Summary
        7.10.2 Lunan Business Overview
        7.10.3 Lunan Oncology & Cancer Drugs Major Product Offerings
        7.10.4 Lunan Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
        7.10.5 Lunan Key News & Latest Developments
    7.11 Eli Lilly and Company
        7.11.1 Eli Lilly and Company Company Summary
        7.11.2 Eli Lilly and Company Business Overview
        7.11.3 Eli Lilly and Company Oncology & Cancer Drugs Major Product Offerings
        7.11.4 Eli Lilly and Company Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
        7.11.5 Eli Lilly and Company Key News & Latest Developments
8 Global Oncology & Cancer Drugs Production Capacity, Analysis
    8.1 Global Oncology & Cancer Drugs Production Capacity, 2019-2030
    8.2 Oncology & Cancer Drugs Production Capacity of Key Manufacturers in Global Market
    8.3 Global Oncology & Cancer Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Oncology & Cancer Drugs Supply Chain Analysis
    10.1 Oncology & Cancer Drugs Industry Value Chain
    10.2 Oncology & Cancer Drugs Upstream Market
    10.3 Oncology & Cancer Drugs Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Oncology & Cancer Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
Email: inquiry@wiredrelease.com
SHORT NAVIGATION
connect with us